5/14/2019 9:02:04 AM
Abbott Partners With NIH On BRAIN Initiative To Advance Research For Neurological Disorders
5/6/2019 9:03:30 AM
Abbott Unveils Next-generation Detection Technology In U.S. And Europe
5/2/2019 8:02:48 AM
Abbott Receives WHO Prequalification Approval For Breakthrough HIV Point-of-Care Test
4/30/2019 9:03:15 AM
Abbott Announces Next Phase Of Partnership With DoD And Researchers From TRACK-TBI Network
4/29/2019 5:41:32 AM
Abbott's Troponin-I Blood Test To Predict Future Cardiac Events In Adults
4/17/2019 7:47:31 AM
Abbott Q1 Worldwide Sales Of $7.5 Bln, Increase 2.0% On Reported Basis And 7.1% On Organic Basis
3/19/2019 8:03:02 AM
Abbott Announces CE Mark For Alinity™ M Diagnostics System And Assays
3/17/2019 12:45:17 PM
New Data For Abbott's HeartMate 3 Highlights Unparalleled Performance Of Heart Pump
3/14/2019 2:17:40 PM
Abbott Receives FDA Approval For Expanded Indication For MitraClip Device
3/6/2019 9:03:54 AM
Late-Breaking Data Presentations At ACC 2019 Highlight Abbott's Cardiovascular Portfolio
2/22/2019 11:09:07 AM
Abbott Laboratories (ABT) Declares Quarterly Dividend of $ 0.32, Record Date 4/15/2019
2/22/2019 10:41:11 AM
Abbott Declares Quarterly Dividend Of $0.32, Payable May 15/ Record April 15
2/20/2019 9:01:25 AM
Abbott And Novo Nordisk To Provide Integrated Digital Solution To People With Diabetes Using Insulin